The price of Sagimet Biosciences Inc (NASDAQ: SGMT) closed at $5.31 in the last session, down -1.30% from day before closing price of $5.38. In other words, the price has decreased by -$0.07 from its previous closing price. On the day, 561874 shares were traded.
Ratios:
We take a closer look at SGMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.04 and its Current Ratio is at 17.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On August 08, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $67.Piper Sandler initiated its Overweight rating on August 08, 2023, with a $67 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 26 ’24 when Happel David bought 12,100 shares for $5.27 per share. The transaction valued at 63,731 led to the insider holds 639,200 shares of the business.
Happel David bought 1,600 shares of SGMT for $6,560 on Dec 07 ’23. The President & CEO now owns 627,100 shares after completing the transaction at $4.10 per share. On Nov 16 ’23, another insider, Happel David, who serves as the President & CEO of the company, bought 590 shares for $2.35 each. As a result, the insider paid 1,386 and bolstered with 590 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 171.70M and an Enterprise Value of 76.86M. For the stock, the TTM Price-to-Sale (P/S) ratio is 60.80 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 38.43 whereas that against EBITDA is -2.50.
Stock Price History:
Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is 6.41, while the 200-Day Moving Average is calculated to be 8.05.
Shares Statistics:
According to the various share statistics, SGMT traded on average about 1.78M shares per day over the past 3-months and 767.26k shares per day over the past 10 days. A total of 21.38M shares are outstanding, with a floating share count of 12.11M. Insiders hold about 47.11% of the company’s shares, while institutions hold 53.11% stake in the company. Shares short for SGMT as of Mar 28, 2024 were 2.35M with a Short Ratio of 1.00, compared to 1.62M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.36% and a Short% of Float of 9.48%.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.29 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$1.53 and -$2.62 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$3.7, with 5 analysts recommending between -$2.62 and -$4.53.
